UCSF Health has been recognized as a top performer in the 2025 Bernard A. Birnbaum, MD, Quality Leadership Ranking by Vizient ...

UCSF is partnering with physicians across the country to develop a pediatric cancer environmental referral service. The ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC ...

Ngo, a third-year student in the UCSF School of Dentistry. As a daughter and granddaughter of Asian immigrants, Belle’s ...

The start of a new academic year is a special time, full of promise for the next generation of leaders in the health sciences ...

A UCSF headache specialist discusses how to identify and treat children's headaches, emphasizing prevention and new ...

A study screened dyes found in textiles and in the laser industry that can be used in imaging for preclinical studies to ...

Christine Miaskowski, RN, PhD, FAAN, internationally recognized expert in pain and symptom management research and professor ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...

Psilocybin, a natural compound found in certain mushrooms, has shown promise in treating depression and anxiety. UC San Francisco researchers wanted to know if it could be used to help Parkinson’s ...

Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson’s disease. Photo by Maurice ...

More than 1.6 million U.S. middle and high school students reported vaping in 2023, and nearly 90% used flavored vapes. But America’s youth vaping epidemic may be no accident. UC San Francisco ...